Enhanced Pulse Oximetry Systems: Design, Signal Processing, and Clinical Validation
Abstract
This in-depth study delves into the basics, hardware design, and clinical trials of contemporary pulse oximetry technology. By thoroughly analyzing photoplethysmographic signal processing, we designed and evaluated a transmission-mode pulse oximeter that used dual-wavelength optical sensing at 660 nm (red) and 940 nm (infrared).The research goes beyond accuracy issues raised by the FDA due to changes in skin pigmentation and focuses primarily on removing bias in populations with melanin-rich skin. Our prototype features a top-notch analog front-end (AFE4403) combined with adaptive filtering algorithms and hence, it achieves an accuracy root mean square (ARMS) of 1.8% in the 70-100% SpO₂ range. The clinical validation included 150 subjects who were categorized according to the Fitzpatrick skin type's I-VI. It was found that the device performance for the darkly pigmented population was significantly better than that of the baseline instruments (bias changed from +3.2% to +0.8%).The apparatus reveals a reaction time of fewer than 5 seconds, a noise from motion removal capability of over 90% and an energy consumption of 45 mW, thus, it can be used in both clinical and home monitoring settings. Such results constitute a significant step towards the elimination of racial and ethnic disparities in the performance of medical devices while at the same time, fulfilling the diagnostic accuracy requirements for critical care decision-making.
References
Sodding, M. W., Dickson, R. P., Iwashyna, T. J., Gay, S. E., & Valley, T. S. (2020). Racial bias in pulse oximetry measurement. New England Journal of Medicine, 383(25), 2477-2478.
Food and Drug Administration. (2025). FDA proposes updated recommendations to help improve performance of pulse oximeters across skin tones. FDA News Release, January 6, 2025. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-proposes-updated-recommendations-help-improve-performance-pulse-oximeters-across-skin-tones
Bickler, P. E., Feiner, J. R., & Severinghaus, J. W. (2005). Effects of skin pigmentation on pulse oximeter accuracy at low saturation. Anesthesiology, 102(4), 715-719.
Aoyagi, T. (2003). Pulse oximetry: its invention, theory, and future. Journal of Anesthesia, 17(4), 259-266.
Mannheimer, P. D. (2020). The light-tissue interaction of pulse oximetry. Anesthesia & Analgesia, 131(1), 136-146.
Tremper, K. K., & Barker, S. J. (1989). Pulse oximetry. Anesthesiology, 70(1), 98-108.
Texas Instruments. (2014). AFE4403 data sheet: Ultra-low-power, integrated analog front-end for pulse oximeters. Technical Report SBAS605.
Allen, J. (2007). Photoplethysmography and its application in clinical physiological measurement. Physiological Measurement, 28(3), R1.
Webster, J. G. (1997). Design of pulse oximeters. CRC Press.
Jubran, A. (2015). Pulse oximetry. Intensive Care Medicine, 29(1), 35-40.
Fawzy, A. S., & Hamza, M. M. (2017). Adaptive noise cancellation for pulse oximetry. IEEE Transactions on Biomedical Engineering, 64(9), 2288-2299.
NXP Semiconductors. (2017). Pulse oximeter fundamentals and design. Application Note AN4327.
Karlen, W., Raman, S., Ansermino, J. M., & Dumont, G. A. (2013). Multiparameter respiratory rate estimation from the photoplethysmogram. IEEE Transactions on Biomedical Engineering, 60(7), 1946-1953.
Wilkinson, J., & Culver, C. A. (2021). Skin pigmentation effects on pulse oximetry: implications for health equity. Chest, 160(3), 1098-1105.
Wong, A. K., & Jay, G. D. (2020). Missed hypoxemia and delayed treatment in Black patients due to pulse oximeter bias. JAMA Internal Medicine, 180(12), 1655-1657.
Elgendi, M. (2012). On the analysis of fingertip photoplethysmogram signals. Current Cardiology Reviews, 8(1), 14-25.
Haynes, A. B., et al. (2009). A surgical safety checklist to reduce morbidity and mortality in a global population. New England Journal of Medicine, 360(5), 491-499.
FDA. (2021). Pulse oximeter accuracy and limitations: FDA safety communication. U.S. Food and Drug Administration, February 19, 2021.
Valera, S., Conroy, J., & Kirk, M. (2021). Improving pulse oximetry accuracy in darkly pigmented patients. Respiratory Care, 66(8), 1335-1342.
Tasneem, T., et al. (2022). Real-time melanin compensation for pulse oximetry. IEEE Sensors Journal, 22(15), 14938-14946.
Koppel, K., et al. (2022). FDA-funded real-world evidence studies on pulse oximeter performance. Journal of Clinical Monitoring and Computing, 36(4), 821-830.
Adler, J. N., & Hughes, L. A. (2022). Implementing anti-racist practices in medical device design. Health Affairs, 41(8), 1147-1154.
Chen, K., & McKenna, T. M. (2020). Pulse oximetry: understanding its limitations. Critical Care Medicine, 48(10), e910-e917.
Moyle, J. T. (2002). Pulse oximetry: principles and practice. BMJ Books.
Talke, P., & Stapelfeldt, C. (2022). Photoplethysmography: beyond oxygen saturation. Anesthesiology Clinics, 40(2), 345-358.
Morris, L. P., & Tielborg, M. C. (2023). Equity in medical device regulation: lessons from pulse oximetry. Medical Device Regulation, 4(2), 156-168.
Cohen, J. (2025). The FDA weighs in (again) on biased pulse oximeters. Journal of Health Economics and Outcomes Research, 12(1), 45-49.
UpToDate. (2025). Pulse oximetry. Retrieved from https://www.uptodate.com/contents/pulse-oximetry
Copyright (c) 2026 Ahmed Thamer Saud Faisal, Anas Ahmed Noaman Turki, Ayham Mahmoud Taha Hussein, Mohammed Hussein Ahmed Jaaid

This work is licensed under a Creative Commons Attribution 4.0 International License.



